Apalutamide (APA) and overall survival (OS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Updated results from the phase III SPARTAN study
医学
前列腺癌
肿瘤科
内科学
妇科
癌症
作者
Matthew R. Smith,Fred Saad,S. Chowdhury,Stéphane Oudard,Boris Hadaschik,Julie N. Graff,David Olmos,Paul N. Mainwaring,J.Y. Lee,Hiroji Uemura,Peter De Porre,Alexis K. Smith,K. Zhang,Angela Lopez‐Gitlitz,Eric J. Small